Staging of α-synuclein in the olfactory bulb in a model of Parkinson's disease: Cell types involved

Movement Disorders

Volumn 25, Issue 11, 2010, Pages 1701-1707

  Ubeda Bañon, Isabel ^a   Saiz Sanchez, Daniel ^a   De La Rosa Prieto, Carlos ^a   Mohedano Moriano, Alicia ^a   Fradejas, Noelia ^a   Calvo, Soledad ^a   Argandoña Palacios, Lucia ^b   Garcia Muñozguren, Susana ^b   Martinez Marcos, Alino ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

synuclein; Calcium binding protein; Olfactory bulb; Olfactory deficit; Parkinson's disease; Transgenic mice; Tyrosine hydroxylase

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM BINDING PROTEIN; GLUTAMIC ACID; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; INTERNEURON; MITRAL CELL; MOUSE; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEURONS; OLFACTORY BULB; PARKINSON DISEASE; PARVALBUMINS; TYROSINE 3-MONOOXYGENASE; UBIQUITINS;

EID: 77955824471     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23197     Document Type: Article

References (33)

1. Chaudhuri KR, Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol 2008;255(Suppl 5):33-38.
2. Tolosa E, Gaig C, Santamaria J, Compta Y. Diagnosis and the pre-motor phase of Parkinson disease. Neurology 2009;72:S12-S20.
3. Rodriguez-Oroz MC, Jahanshahi M, Krack P, et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009;8:1128-1139.
4. Hawkes CH, Doty RL. The Neurology of Olfaction. Cambridge: Cambridge University Press, 2009.
5. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
6. Smutzer GS, Doty RL, Arnold SE, Trojanowski JQ. Olfactory system neuropathology in Alzheimer's disease, Parkinson's disease, and Schizophrenia. In: Doty RL, ed. Handbook of Olfaction and Gustation, second ed. New York: Marcel Dekker, Inc., 2003. p503-523.
7. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388:839-840.
8. Mosharov EV, Larsen KE, Kanter E, et al. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 2009;62:218-229.
9. Dawson T, Mandir A, Lee M. Animal models of PD: pieces of the same puzzle? Neuron 2002;35:219-222.
10. Sengoku R, Saito Y, Ikemura M, et al. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 2008;67:1072-1083.
11. Olanow CW, Kordower JH. Modeling Parkinson's disease. Ann Neurol 2009;66:432-436.
12. Saiz-Sanchez D, Ubeda-Banon I, de la Rosa-Prieto C, et al. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease. Exp Neurol 2009; doi:10.1016/j.expneurol.2009.06.010.
13. Guillery RW. On counting and counting errors. J Comp Neurol 2002;447:1-7.
14. Coleman P, West MJ. How to count. Neurobiol Aging 1996;17:503.
15. West MJ. New stereological methods for counting neurons. Neurobiol Aging 1993;14:275-285.
16. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239-247.
17. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 2002;34:521-533.
18. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
19. van der Putten H, Wiederhold KH, Probst A, et al. Neuropathology in mice expressing human alpha-synuclein. J Neurosci 2000;20:6021-6029.
20. Sommer B, Barbieri S, Hofele K, et al. Mouse models of alpha-synucleinopathy and Lewy pathology. Exp Gerontol 2000;35:1389-1403.
21. Lee MK, Stirling W, Xu Y, et al. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A 2002;99:8968-8973.
22. Fleming SM, Fernagut PO, Chesselet MF. Genetic mouse models of parkinsonism: strengths and limitations. NeuroRx 2005;2:495-503.
23. Chesselet MF, Fleming S, Mortazavi F, Meurers B. Strengths and limitations of genetic mouse models of Parkinson's disease. Parkinsonism Relat Disord 2008;14(Suppl 2):S84-S87.
24. Chesselet MF. In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease? Exp Neurol 2008;209:22-27.
25. Tofaris GK, Garcia Reitbock P, Humby T, et al. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J Neurosci 2006;26:3942-3950.
26. Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 2008;28:247-256.
27. Becker G, Muller A, Braune S, et al. Early diagnosis of Parkinson's disease. J Neurol 2002;249(Suppl 3):III40-III48.
28. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008;63:167-173.
29. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181.
30. Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992;340:186.
31. Kosaka K, Heizmann CW, Kosaka T. Calcium-binding protein parvalbumin-immunoreactive neurons in the rat olfactory bulb. 2. Postnatal development. Exp Brain Res 1994;99:205-213.
32. Wouterlood FG, Hrtig W. Calretinin-immunoreactivity in mitral cells of the rat olfactory bulb. Brain Res 1995;682:93-100.
33. Heinbockel T, Heyward P, Conquet F, Ennis M. Regulation of main olfactory bulb mitral cell excitability by metabotropic glutamate receptor mGluR1. J Neurophysiol 2004;92:3085-3096.